Shimonishi T, Sasaki M, Nakanuma Y
Second Department of Pathology, Kanazawa University School of Medicine, Kanazawa 920-8640, Japan.
J Hepatobiliary Pancreat Surg. 2000;7(6):542-50. doi: 10.1007/s005340070002.
Intrahepatic cholangiocarcinoma (ICC), also known as cholangiocellular carcinoma or peripheral bile duct carcinoma, is an intrahepatic malignant tumor that consists of cells resembling the biliary epithelium. The proportion of ICC among primary hepatic malignancies is approximately 10% worldwide. Although the etiology and pathogenesis remain unclear in a great majority of cases, preceding pathologic conditions or etiologies in the development of ICC are known or suspected in a proportion of these patients. Some forms of ICC, such as those associated with hepatolithiasis or liver fluke infestation, are endemic in parts of the world, particularly in East Asia. ICC is reportedly a late complication of primary sclerosing cholangitis. Most of these preceding pathologic conditions are forms of chronic cholangitis, and longstanding inflammation, chronic injury, and regenerative hyperplasia of the biliary epithelium may be causally related to malignant transformation. Biliary epithelial dysplasia is encountered in the intrahepatic bile ducts both near and remote from ICC foci in the liver and near and remote from the chronically inflamed biliary tree. This lesion could be a precancerous lesion, and it shows telomerase activity and increased proliferative activities. Furthermore, congenital and developmental disorders of the biliary system, such as Caroli's disease, congenital hepatic fibrosis, and pancreatico-biliary malformation are occasionally associated with ICC. Benign biliary tumors, such as biliary papillomatosis, may eventually undergo malignant transformation. These lesions could be regarded as precancerous or borderline lesions. Some ICCs may also develop in nonbiliary viral cirrhosis. In the majority of cases of ICC, however, the etiology, pathogenesis, and developmental processes and precancerous lesions of the ICC remain unclear.
肝内胆管癌(ICC),也称为胆管细胞癌或周围胆管癌,是一种肝内恶性肿瘤,由类似于胆管上皮的细胞组成。在全球范围内,ICC在原发性肝脏恶性肿瘤中所占比例约为10%。尽管在大多数病例中病因和发病机制仍不清楚,但在一部分此类患者中,已知或怀疑ICC发生之前存在病理状况或病因。某些形式的ICC,如与肝内胆管结石或肝吸虫感染相关的ICC,在世界部分地区呈地方性流行,尤其是在东亚。据报道,ICC是原发性硬化性胆管炎的晚期并发症。这些先前的病理状况大多是慢性胆管炎的形式,长期炎症、慢性损伤和胆管上皮的再生性增生可能与恶性转化有因果关系。在肝脏中距ICC病灶远近不同的肝内胆管以及距慢性炎症胆管树远近不同的部位,均可发现胆管上皮发育异常。这种病变可能是癌前病变,并且显示端粒酶活性和增殖活性增加。此外,胆管系统的先天性和发育性疾病,如卡罗里病、先天性肝纤维化和胰胆管畸形,偶尔也与ICC相关。良性胆管肿瘤,如胆管乳头状瘤病,最终可能会发生恶性转化。这些病变可被视为癌前或临界病变。一些ICC也可能在非胆汁性病毒性肝硬化中发生。然而,在大多数ICC病例中,其病因、发病机制、发展过程和癌前病变仍不清楚。